Getinge AB (publ) (GETI_B) Q2 2026 Earnings Call

Investor webinar replay

Replay transcript excerpt

Welcome to the Jettinga Q2 Report 2026. During the questions and answers session, participants are able to ask questions by dialing pound key 5 on their telephone keypad. Now I will hand the conference over to the speakers, CEO Matthias Peerjus and CFO Agneta Palmer. Please go ahead. The live has now started. Hi everyone and welcome to today's conference call. With me today I have Agneta Palmier, our CFO, and in today's conference we'll go through our performance and some highlights for the second quarter before opening up for a Q&A. So we can move over to page number two, please. And as usual, let's start by looking at the development of our strategic KPIs. We continue to clearly track in line with plan to increase the share of sales from recurring revenue, accelerating the share of sales from high-margin products like, for example, our ECLS offering, consumables in infection control, and beta bags in sterile transfer. This is all supported by solid and effective quality processes and sales from recurring revenue continue to make up about two thirds and high margin products are now at 70%. For quality, the number of field actions in relation to sales has decreased significantly and we're pacing a lot better than last year. These improvements should of course be achieved through responsible leverage and also an attractive long-term return on invested capital. With that we can move over to page number three, please. So if we zoom in on the second quarter and some of the financial key takeaways for the quarter. Overall, we deliver a healthy financial performance in the quarter with solid top line growth. Net sales grew 4.6% organically and with positive development in most of the business areas. Order intake increased by 6.2% organically. Adjusted gross and EBITDA marg...